Stay updated on VK2809 Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the VK2809 Efficacy in NASH Clinical Trial page.

Latest updates to the VK2809 Efficacy in NASH Clinical Trial page
- CheckyesterdayChange DetectedRemoved the MeSH topic 'Non-alcoholic fatty liver disease' and the related topic 'MedlinePlus Genetics' from the study record, reducing the displayed related topics.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page shows Revision: v3.3.4 replacing v3.3.3; there are no changes to study details or user-facing functionality observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now includes additional related-topic links to Non-alcoholic fatty liver disease and MedlinePlus Genetics.SummaryDifference0.1%

- Check29 days agoChange DetectedAdded a comprehensive Locations section with state- and country-level site entries (e.g., Alabama, California, Guerrero, Nuevo León) and removed individual location groupings (e.g., Alabama Locations, Guerrero Locations).SummaryDifference2%

- Check37 days agoChange DetectedAdded related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics under the Related Topics section.SummaryDifference0.1%

- Check44 days agoChange DetectedRelated topics such as 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics' were removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to VK2809 Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VK2809 Efficacy in NASH Clinical Trial page.